B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 247.05M 229.91M 150.05M -141.59M 175.23M
Total Depreciation and Amortization 34.20M 33.97M 33.73M 26.68M 20.42M
Total Amortization of Deferred Charges 2.22M 2.25M 2.25M 1.95M 1.86M
Total Other Non-Cash Items 11.84M 18.32M 20.25M 341.42M 39.37M
Change in Net Operating Assets -37.03M -43.57M -26.20M -9.43M -58.28M
Cash from Operations 258.27M 240.89M 180.08M 219.03M 178.60M
Capital Expenditure -3.05M -4.17M -3.74M -1.43M -3.03M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 0.00 0.00 710.00K -725.97M --
Divestitures -- -- -- -- --
Other Investing Activities 24.00M -58.49M 154.00K -14.40M 204.64M
Cash from Investing 20.95M -62.66M -2.88M -741.79M 201.61M
Total Debt Issued 1.47B -- -- 1.47B --
Total Debt Repaid -651.79M -- -- -1.01B --
Issuance of Common Stock 22.80M 4.87M -- 4.15M 16.48M
Repurchase of Common Stock -67.27M -331.12M -1.61M 0.00 -38.88M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -187.97M -- -- -221.24M --
Cash from Financing 587.65M -326.25M -1.61M 239.52M -22.40M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 866.86M -148.02M 175.59M -283.24M 357.80M